A phase II study of pembrolizumab, carboplatin, paclitaxel, and radiation for the treatment of early-stage anal cancer: Big Ten Cancer Research Consortium GI22-588.
Authors: Anita Turk, Salma K. Jabbour, Yixing Jiang, Dustin A. Deming
Published: 2025-05-28
DOI:
10.1200/jco.2025.43.16_suppl.tps3633
Source:
Full article
Abstract
TPS3633